ISRCTN88858357
Completed
未知
Real-world study of the management and outcomes of patients with frontline transplant-eligible multiple myeloma in four European countries (France, Germany, Spain and Italy)
Kantar Health (France)0 sites804 target enrollmentNovember 22, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Frontline transplant-eligible multiple myeloma
- Sponsor
- Kantar Health (France)
- Enrollment
- 804
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Study population 1 (ongoing FLTE MM population):
- •1\. Being on an ongoing frontline therapy line
- •2\. Being considered either fit for transplant at initial diagnosis, or planned on transplant while on frontline therapy, or having already been transplanted while on frontline therapy
- •Study population 2 (previous FLTE MM population):
- •1\. Being on an ongoing relapse or refractory multiple myeloma therapy line
- •2\. Having received a previous frontline therapy line
- •3\. Being considered either fit for transplant at initial diagnosis, or having already been transplanted while on frontline therapy
Exclusion Criteria
- •Study population 1 (ongoing FLTE MM population):
- •1\. Receiving the ongoing frontline therapy as part of a randomized controlled trial or early access program
- •Study population 2 (previous FLTE MM population):
- •1\. Having initiated the frontline induction prior to 2017
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
pva reviewPatients who need to be connected to a ventilator due to breathing problems or other problems.IRCT20231001059572N1Ahvaz University of Medical Sciences60
Recruiting
Phase 4
Study of advanced renal tumorsCTRI/2016/09/007317King George Medical University20
Not yet recruiting
Phase 1
Study on the intervention and management model of metabolic syndrome with hyperuricemia based on ''state'' identification -- a cross-sectional study of metabolic syndrome with hyperuricemiahyperuricemia, Metabolic syndrome, GoutITMCTR2022000047Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Not yet recruiting
Phase 1
Study on the intervention and management model of metabolic syndrome complicated with hyperuricemia based on ''state'' identification --Study on comprehensive intervention in acute stage of metabolic syndrome complicated with goutMetabolic syndrome\GoutITMCTR2022000046Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Not yet recruiting
Not Applicable
Real-world evaluation and applied research on the treatment of irritable bowel syndrome with the method of regulating the mind and strengthening spleeIrritable bowel syndromeITMCTR2100005387Jiangsu Province Traditional Chinese Medicine Hospital